HANS BIOMED USA, Inc. 140 sylvan Ave Suite #4 Englewood Cliffs, NJ TEL FAX:

Similar documents
We invite you to learn more with the enclosed information or through our websites and

Certifications: Table of Contents. Document # Title Page(s)

2015-Tissue Storage. Welcome to the 2015 Tissue Storage survey. Please refer to the following instructions as you complete this section of the survey.

Importing/Exporting Conventional HCT/Ps

HCT/P Regulation vs 361 Products

2015-Tissue Bank Processing

FDA Approach to the Regulation of Hematopoietic Stem/Progenitor Cells (HPC)

Special Report. medicine? Peter Marks, M.D., Ph.D., and Scott Gottlieb, M.D.

IS HE SPEAKING ENGLISH? cgmp: : Current Good Manufacturing Practice PHS Act: : Public Health Service Act CFR: : Code of Federal Regulations CP: : Comp

FAQ ABOUT. 21CFR Part 1271 FDA REGULATION OF REPRODUCTIVE TISSUE LABS

Patient Handbook on Stem Cell Therapies

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

07/30/2013. Record of Revisions IRB Page 1 of 17

MIIG INJECTABLE Graft The following languages are included in this packet:

Stem Cells 101. Christopher Centeno, M.D. The Centeno-Schultz Clinic Colorado, USA

Challenges In Cell Product Labeling, Tracking And Traceability

Postmarketing Safety Reporting and cgmp Requirements for Combination Products. Katlin McKelvie Backfield November 2, 2017

PRO-STIM Injectable Inductive Graft Containing DONATED HUMAN TISSUE

Tissue Engineered Medical Products

Regulatory Updates on Cellular Therapy Products in Japan

HCT/P Deviations & Reporting. 13 th ANNUAL FDA & The Changing Paradigm for HCT/P Regulation February 13-15, 2017

Des cellules-souches dans le poumon : pourquoi faire?

#SIS25th. 25th Annual Meeting Slides

COMBINATION PRODUCTS. Karyn M. Campbell, Director Investigations Branch Philadelphia District Office Food and Drug Administration

YOUR OWN LIFE

Embryonic Stem Cell Research Oversight Committee (ESCRO) Application Form

NEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY:

Document issued on: March 19, The draft of this document was issued on May 20, 2010.

Background. Background. Background. Background. Background 3/4/2013

NORIAN DRILLABLE TECHNICAL MONOGRAPH. Fiber reinforced calcium phosphate phate bone void filler

UNIQUE DEVICE IDENTIFICATION U.S. FDA. March 2014

Cell Therapy Services Your Product. Our Passion.

Alliance for Regenerative Medicine

From Stem Cell to Any Cell

Stem Cells. Part 1: What is a Stem Cell? STO Stem cells are unspecialized. What does this mean?

Regenerative Medicine. Speaker Disclosures. What is regenerative medicine? 6/22/2016

Medidée Services SA. Nano-Tera.ch. 05 February 2015 part 8. PMA, 510k, IDE. Pierre-Alain Sommer

Cellular Therapy Products & NDC vs. ISBT128 Coding/Labeling

Janice Soreth, M.D. Deputy Director FDA Europe Office Liaison to EMA. Making Gene and Cell Therapy a Reality July 10-11, 2012 Dublin

THE RIGENERA PROJECT

Internationally Standardized Terminology for Regenerated Tissue

UNIT CELL PROCESSES UNDERLYING TISSUE ENGINEERING AND REGENERATIVE MEDICINE

Scientists have successfully used stem cells to reverse this paralysis. Magnification 0.02

ANAT 3231 Cell Biology Lecture 21 Stem Cells

Chapter 7 RECALL PROCEDURES

TissueMend Soft Tissue Repair Matrix For Biologically Inspired Augmentation of Tendon Healing. Technical Q&A

Regulatory Implications for Global Manufacturing Development of Regenerative Medicines

Copyright. Jeremiah J. Kelly (2015). All rights reserved. Further dissemination without express written consent strictly prohibited.

Platelet Concentrate in Total Knees BIOLOGICS. This brochure is for International use only. It is not for distribution in the United States.

Stem Cells Canadian Perspective

Animal Origin Position Statement

Regulatory Pathways for Rare Diseases

ANAT 2341 Embryology Lecture 18 Stem Cells

Adipose rabbit mesenchymal stem cells for the treatment of the chronic scar tissue of the vocal cords

December 18, 2014 Approval Letter - INTERCEPT Blood System for Platelets

Utilization of UDI during the Product Recall. 18 September 2015 Terumo Cardiovascular Group Eileen Dorsey

Recent FDA Inspection Findings and Trends

Collagen Solutions Plc

Information and resources for African Americans living with multiple myeloma and their caregivers

University Health Network UDI Capture Work Group Case Study

2016 North American Cell Therapeutics Technology Innovation Award

What Are Stem Cells? Where Are These Stem Cells?

Updates on global movement in regulation of Advanced Therapeutics

Mitochondrial Manipulation Technologies: Preclinical Considerations

APPLICATION FOR SITE INSPECTION Eye Bank Association of America

REQUEST FOR AUTHORISATION TO THE COMPETENT AUTHORITY: REQUEST FOR OPINION OF THE ETHICS COMMITTEE:

The Role of Standards in U.S. FDA Regulation of Cellular Therapy Products

PACT. PACT Program. Production Assistance for Cellular Therapies

Plamena Entcheva-Dimitrov, PhD, RAC On-line Course.

Hematopoietic Stem Cells: Cell Processing, and Transplantation

C D R H. Computational Modeling in Medical Devices. Prasanna Hariharan, PhD

The New News in Stem Cell Research Andrés Bratt-Leal, PhD 12/1/2017

cell body c) What is the central nervous system? What is the peripheral nervous system?

Health Products and Food Branch Inspectorate

Tissue Engineering For Regenerating Life. Cryopreserved Products. Tissue Corporation

Natural Fibers and Innovative

Life Valve Project (FP7)

Stem cells and motor neurone disease

Embryonic development, epigenics and somatic cell nuclear transfer - The science and its social implications -

The transition to OptumRx is designed to help us better serve your employees and help improve their overall experience:

Recent advances in tissue-engineered corneal regeneration

HydroSet. Injectable HA Bone Substitute

Chapter 8 Cell Diversity

PhysicsAndMathsTutor.com. Question Number. Answer Additional guidance Mark. 1(a) 1. reference to stem cells being {totipotent / pluripotent} ;

Overview of USP Efforts to Identify Naming Schemes for Tissues and Tissue-Based Products

The transfer of all HPC products should be transferred to and from the courier in a clinical setting.

Cell and Gene Therapy Medicinal Product Management Act (Draft) General Information

Artist Proof: Clotalyst. Autologous Serum Collection System

Supplemental Information. Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry. Leigh Turner and Paul Knoepfler

At the conclusion of this lesson you should be able to:

5.5. Multicellular Life. Multicellular organisms depend on interactions among different cell types.

Should Embryonic Stem Cell Research be Permitted to Continue? Over the past few years a debate has been going on over the moral implications of

Fundamental properties of Stem Cells

Project Proposal Ultrasound Mediated Tissue Engineering Project Team 21

European Regenerative Medicine Firms & Their Strategic Approaches. Michael Morrison University of York

WHITE PAPER: ATELO COLLAGEN. Product Number: FS22001, FS22002, FS22003, FS22004, FS22005, FS22006

Transcription:

HANS BIOMED USA, Inc. 140 sylvan Ave Suite #4 Englewood Cliffs, NJ 07632 TEL 201 2242333 FA: 201 221 2330 Aug 2, 2016 To Whom it May Concern, Hans Biomed manufactures ExponentT M DBM and PureBone Demineralized Cancellous products for Bioventus. ExponenPM DBM product was cleared under the trade name SurFuse Gel and Putty and ExFuse Gel and Putty (the clearance letter can be downloaded directly from www.fda.gov). ExponentT M DBIVI products are indicated for bony voids or gaps that are not intrinsic to the stability of the bony structure. They are intended to be gently packed into bony voids or gaps of the skeletal system (posterolateral spine). These defects may be surgically creased osseous defects or osseous defects created from traumatic injury to the bone. Should you have any further questions, please feel free to contact me directly. Best regards, Hans Biomed USA, Inc. WWW HANSBIOMED. COM

12. HCT/Ps REGULATED AS MEDICAL DEVICES 11. HCT/Ps DESCRIBED IN 21 CFR 1271.10 DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION ESTABLISHMENT REGISTRATION AND LISTING FOR HUMAN CELLS, TISSUES, AND CELLULAR AND TISSUE-BASED PRODUCTS (HCT/Ps) (See reverse side for instructions) PART I - ESTABLISHMENT INFORMATION 3. OTHER FDA REGISTRATIONS a. BLOOD FDA 2830 b. DEVICES FDA 2891 NO. NO. d. INACTIVE PART II - PRODUCT INFORMATION 10. ESTABLISHMENT FUNCTIONS AND TYPES OF HCT / Ps Establishment Functions Types of HCT / Ps FEI: 3003828812 See Instructions for OMB Statement. FORM APPROVED:OMB No.0910-0543. Expiration Date: 3/31/2017 1. REGISTRATION NUMBER 2. REASON FOR SUBMISSION (FDA Establishment Identifier) a. INITIAL REGISTRATION / LISTING b. ANNUAL REGISTRATION / LISTING c. CHANGE IN INFORMATION Recover Screen Test Package Process Store Label Distribute VALIDATION--FOR FDA USE ONLY VALIDATED BY FDA:21-DEC-2014 DISTRICT: Int'l Operations Group PRINTED BY FDA:02-FEB-2015 13. HCT/Ps REGULATED AS DRUGS OR BIOLOGICAL DRUGS 14. PROPRIETARY NAME(S) 1 c. DRUG FDA 2656 NO. 4. PHYSICAL LOCATION (Include legal name, number and street, city, state, country, and post office code) Hans Biomed Corporation a. Bone b. Cartilage *** See full text on next page 64, yuseong-daero 1628 beon-gil Youseong-gu, Daejeon, KR-30 Korea, Republic Of c. Cornea d. Dura Mater a. PHONE 822-466-2266 ET b. SATELLITE RECOVERY ESTABLISHMENT (MANUFACTURING ESTABLISHMENT FEI NO. c. TESTING FOR MICRO-ORGANISMS ONLY 5. ENTER CORRECTIONS TO ITEM 4 e. Embryo f. Fascia g. Heart Valve h. Ligament SIP Directed Anonymous Bellagen-F 6. MAILING ADDRESS OF REPORTING OFFICIAL (Include institution name if applicable, number and street, city, state, country, and post office code) Hans Biomed Corporation Attn: Lucy Choi c/o Calways 105 Welker Ct Campbell, California 95008 i. Oocyte j. Pericardium k. Peripheral Blood Stem l. Sclera SIP Directed Anonymous Autologous Family Related Allogeneic a. PHONE 408-676-9063 ET 7. ENTER CORRECTIONS TO ITEM 6 b. PHONE m. Semen n. Skin SIP Directed Anonymous *** See full text on next page 8. U.S. AGENT Shane Liu, RAC Calways International, LLC 105 Welker Ct, Campbell, California 95008 o. Somatic Cell Therapy Products p. Tendon q. Umbilical Cord Blood Autologous Family Related Allogeneic Autologous Family Related Allogeneic a. E-MAIL fda@calways.net 9. REPORTING OFFICIAL'S SIGNATURE a. TYPED NAME Lucy Choi b. E-MAIL fda@calways.net c. TITLE Regulatory Affairs Manager FORM FDA - 3356 (5/14) 408-676-9063 d. DATE 20-DEC-2014 r. Vascular Graft s. t. u. v.

DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION ESTABLISHMENT REGISTRATION AND LISTING FOR HUMAN CELLS, TISSUES, AND CELLULAR AND TISSUE-BASED PRODUCTS (HCT/Ps) (See reverse side for instructions) ADDITIONAL INFORMATION: 1. REGISTRATION NUMBER (FDA Establishment Identifier) FEI: 3003828812 See Instructions for OMB Statement. FORM APPROVED:OMB No.0910-0543. Expiration Date: 3/31/2017 2 Proprietary Name(s): a. Bone SureOss, OsteoGrow, SureChip, SureBlock, Genesis, Pedi-Stick, INGROSS, CANOSS, OsteOss, Genesis Sponge, ExFuse, SurFuse, n. Skin Belloderm, Bellagen, SureDerm, Sheba, RegenCell, AlloCover, GPS, CPS FORM FDA - 3356 (5/14) Page: 2